Canada approves world’s first plant-based COVID-19 vaccine

Canada has approved the use of Covifenz, the world’s first plant-derived Covid-19 vaccine jointly developed by Medicago Inc. and GlaxoSmithKline Plc. The vaccine has been cleared for people aged 18 to 64 since its safety and effectiveness, according to Health Canada, have not been established in people younger than 18 or older than 64 years of age.

Points to Note:

  • Covifenz, the world’s first plant-derived Covid-19 vaccine – approved by Canada
  • Covifenz jointly developed by Medicago Inc. and GlaxoSmithKline Plc

 

Click here to read Current Affairs for government exams

Related posts

Leave a Comment